首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1498612

生物技術市場規模、佔有率、成長分析，按類型、按產品、按技術、按應用、按地區 - 產業預測，2024-2031 年

Biotechnology Market Size, Share, Growth Analysis, By Type, By Product(Instrument & Reagent ), By Technology, By Application, By Region - Industry Forecast 2024-2031

出版日期: 2024年06月09日 | 出版商:

SkyQuest | 英文 260 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年生物技術市場規模將為1.21兆美元，從2023年的1.38兆美元成長到2031年的3.9兆美元，在預測期間（2024-2031年）預計複合年成長率為13.9%。

美國、中國和印度人口的成長增加了小麥、米和甘蔗等主食的需求和經濟重要性。同時，科學家們正在深入研究水資源短缺、農業生產力和病蟲害防治等問題的解決方案，重點是創新技術和合作研究。政府和私營部門的舉措正在增加對生物技術的資助並支持研究和產品開發。隨著糖尿病和癌症等慢性疾病在全球範圍內變得越來越普遍，預計生物技術領域對先進治療方法的需求將不斷增加，這為專門從事生物技術創新的公司提供了廣闊的前景。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

AstraZeneca（UK）
Gilead Sciences, Inc.（US）
Biogen Inc.（US）
Merck（Germany）
Illumina, Inc.（US）
Novo Nordisk A/S（Denmark）
Thermo Fisher Scientific Inc.（US）
Agilent Technologies, Inc.（US）
Lonza Group AG（Switzerland）
Pfizer Inc.（US）
Bristol-Myers Squibb（US）
Amgen Inc.（US）
AbbVie Inc.（US）
Regeneron Pharmaceuticals, Inc.（US）
Vertex Pharmaceuticals Incorporated（US）
Roche Holding AG（Switzerland）
Bio-Rad Laboratories, Inc.（US）
Moderna, Inc.（US）
Qiagen NV（Netherlands）
Johnson & Johnson Services, Inc.（US）

簡介目錄

Product Code: SQMIG35H2249

Biotechnology Market size was valued at USD 1.21 Trillion in 2022 and is poised to grow from USD 1.38 Trillion in 2023 to USD 3.90 Trillion by 2031, growing at a CAGR of 13.9% during the forecast period (2024-2031).

The biotech industry is globally interconnected and driven by diverse economic growth across nations, with investments expected to rise due to pressing health challenges like hepatitis B. Population growth in the US, China, and India is increasing demand for staple foods such as wheat, rice, and sugarcane, heightening their economic importance. Concurrently, scientists are intensively researching solutions to issues like water scarcity, agricultural productivity, and pest control, focusing on innovative technologies and collaborations. Government and private sector initiatives bolster biotech funding, supporting R&D and product development. As chronic diseases like diabetes and cancer become more prevalent worldwide, the biotech sector anticipates heightened demand for advanced treatments, offering promising prospects for companies specializing in biotech innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biotechnology Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biotechnology Market Segmental Analysis

The biotechnology market is segmented by type, product, technology, application, and region. Based on type the market is segmented into Blue Biotechnology, Green Biotechnology, Red Biotechnology, White Biotechnology, and Others. Based on product the market is segmented into Instrument & Reagent (Clinical Diagnostics, Proteomics and genomics, Drug Discovery & Development, Cell Analysis, Others), Software & Service. Based on technology, the market can be segmented into Nanobiotechnology, PCR Technology, Bioinformatics, Tissue Engineering, DNA sequencing, Fermentation Technology, and others. Based on application, the market is segmented into Health, Agriculture, Food and Beverages, Industrial Processing, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Biotechnology Market

The biotechnology market is currently driven by advancements in cell and tissue development research, expected to fuel its growth in the coming years. A notable example is Bharat Biotech, an Indian pharmaceutical company, which in August 2022 released phase III clinical trial data for their nasal spray COVID-19 vaccine variant, BBV-154. These trials demonstrated the vaccine's safety and tolerability, receiving approval from the Drug Controller General of India (DCGI) for further comparative studies against Covaxin. This development underscores the market's trajectory towards innovative biotechnological solutions, particularly in vaccine development, influencing the industry's expansion and future prospects significantly.

Restraints in the Biotechnology Market

Legend Biotech Corporation, a U.S.-based biotechnology company specializing in innovative therapies, halted a Phase 1 clinical trial for their CAR-T product after determining it did not meet anticipated outcomes, affecting the biotechnology market's momentum. This decision, communicated to the U.S. FDA, underscores challenges in biotech research where trials may not yield expected clinical benefits. Specifically, in July 2022, Legend Biotech terminated its Investigational New Drug (IND) application for L, a CAR-T therapy, due to findings suggesting no significant therapeutic efficacy akin to their CAR-T product LB1901 under trial in China. Such setbacks can impede growth in the biotechnology sector, influencing investor confidence and research strategies moving forward.

Market Trends of the Biotechnology Market

DNA sequencing has become a pivotal force in the market, driven significantly by cost reductions and the incorporation of advanced techniques. The decreasing expenses and the application of sophisticated methodologies have cemented its critical role in both research and diagnostics, contributing to its widespread acceptance and substantial influence on the market landscape. The increasing accessibility of DNA sequencing not only fosters innovation in genetic research but also enhances its utility in clinical settings, thereby fueling its expansion and market prominence.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Case Study Analysis
Pipeline Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Biotechnology Market by Type

Market Overview
Blue Biotechnology
Green Biotechnology
Red Biotechnology
White Biotechnology
Others

Biotechnology Market by Product

Market Overview
Instrument & Reagent
- Clinical Diagnostics
- Proteomics and genomics
- Drug Discovery & Development
- Cell Analysis
- Others
Software & Service

Biotechnology Market by Technology

Market Overview
Nanobiotechnology
PCR Technology
Bioinformatics
Tissue Engineering and Regeneration
Cell-based Assays
DNA sequencing
Fermentation Technology
Chromatography
Others

Biotechnology Market by Application

Market Overview
Health
Agriculture
Food and Beverages
Natural Resources & Environment
Industrial Processing
Others

Biotechnology Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gilead Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogen Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Nordisk A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Regeneron Pharmaceuticals, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vertex Pharmaceuticals Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Moderna, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Services, Inc.(US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments